Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.
about
Blood pressure control for diabetic retinopathyStandards of medical care in diabetes--2012Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review StudyPrevention, Detection and Management of Coronary Artery Disease in Minority FemalesObesity and kidney protectionPre-hypertension: how low to go and do drugs have a role?Vascular calcification: When should we interfere in chronic kidney disease patients and how?Stop chronic kidney disease progression: Time is approachingGenetics and Epigenetics of Diabetic NephropathyManagement of hypertension in the cardiometabolic syndrome and diabetesStroke prevention in diabetes and obesityAssociation of a CYP4A11 variant and blood pressure in black menHypertensive Cardiovascular and Renal Disease and Target Organ Damage: Lessons from Animal ModelsStandards of medical care in diabetes--2013Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.The choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.Hypertension management in patients with diabetic nephropathy.Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children studyFrom molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.Standards of medical care in diabetes--2010.Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitusDual blockade of the renin-angiotensin system in diabetic nephropathy.Diabetes and drug-associated hyperkalemia: effect of potassium monitoring.Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia.Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalenceEvolving trends in insulin delivery in pursuit of improvements in diabetes management.Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study.Microalbuminuria in diabetes mellitus.Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.Hypertensive nephropathy: prevention and treatment recommendations.Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial.The economic impact of hypertension.Microalbuminuria: what is it? Why is it important? What should be done about it?Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: a prospective observational studyHeight constitutes an important predictor of mortality in end-stage renal disease.Choices and goals in the treatment of the diabetic hypertensive patient.The calcium channel blocker controversy in patients with diabetic nephropathy: Is there an issue?What is the optimal strategy to intensify blood pressure control and prevent progression of renal failure?
P2860
Q24245872-D1BCB34E-C63C-41FA-BF66-EA68094FF7DEQ24632533-DCE4CA27-C51B-4285-8C69-763700FAF8AEQ26740629-2AD12678-6EF5-4171-B2B5-EBDE41128A93Q26775494-C844D799-ADEB-45F9-8E15-80621D8A9656Q27005818-13AFC6D9-AFF9-44AB-A860-7F33E4F6EBF2Q27007552-6849ACCA-4116-4AA2-80C8-478C3C92B33BQ28071582-51A52315-7EDB-4303-B716-26B02E5DFCD2Q28078020-AAC3139C-5842-430F-BEFE-1817E51759EFQ28084549-D8921B5A-4741-4EC2-AA0C-C1FE15612786Q28168564-B6B71B10-D1F8-4805-AB47-7DC2506EC1CAQ28200179-7EFB041C-9CD3-4E90-8001-E233A563E945Q28274987-225507DA-3256-44E2-9024-C628073AAE6CQ28742830-6207F852-B4D7-4578-84F8-887732C596BAQ29620309-7E1D110D-1D60-433E-9388-AECD76D14ED7Q30234498-E651871D-1226-4A6F-B6B8-9F42EDB5461DQ30310671-E8B4BB15-D294-4FB3-98DB-D7922811A3B2Q30433989-C2EBC906-D72F-4E2A-A579-BD3C4113811EQ30502478-3349B858-0A89-497C-B27E-1F9F84B0F014Q33220108-FA6D0555-0D68-49C5-8764-EDBD844DE16EQ33554238-2AC8ACAC-3C02-475D-A95F-97CDBF9810DCQ33561456-E6C86B33-03D8-4666-9668-9695D6A1BFCCQ33585498-344FC8AF-0A5C-44A5-BA24-5F24093F95EFQ33610694-15A3F3CB-D9AF-4297-ADF2-4386D543347AQ33742539-50032AB8-C941-4E7F-B918-5BE23929A8DBQ33804396-07782BDB-F91F-4A18-BC23-F38D93CEA3A2Q33902595-4609DE3E-59EA-4EC3-9023-B01B07D71250Q33932057-E29DF8FF-6585-4136-BEE8-2F3690B4F18EQ33948767-7674A28B-AEF5-4B84-A350-DA188C0965E5Q34004759-94A06640-5C9C-4382-87A9-53BBE5E66A94Q34095380-B4E8352F-8ABA-4AA6-8A71-61D91AB7FEF1Q34131899-71B52C29-39E9-4F57-B7CA-74C3A48B5DDFQ34141784-01352E4E-7CEF-4E2A-8DCE-B41C4699EC5EQ34209022-4B13E213-AE65-4E9E-9E8E-24AB41D058E0Q34287788-43597CFE-A20C-4586-9667-502F2F87130DQ34299778-7372E254-A627-49CF-ADC9-8F052B2D4CD7Q34318842-58117F43-20FB-43B1-96A1-D09670C55C42Q34338764-97B97243-8E72-4003-96A4-FE2B6C028378Q34365043-CF25E6CD-83E1-4583-B33F-32C72A3379E7Q34365083-CA59BE29-50F1-4508-8388-0824B1A44DB1Q34365090-595EC773-0DB6-4B39-B5CC-A59102B65156
P2860
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Preserving renal function in a ...... tive Committees Working Group.
@ast
Preserving renal function in a ...... tive Committees Working Group.
@en
Preserving renal function in a ...... tive Committees Working Group.
@nl
type
label
Preserving renal function in a ...... tive Committees Working Group.
@ast
Preserving renal function in a ...... tive Committees Working Group.
@en
Preserving renal function in a ...... tive Committees Working Group.
@nl
prefLabel
Preserving renal function in a ...... tive Committees Working Group.
@ast
Preserving renal function in a ...... tive Committees Working Group.
@en
Preserving renal function in a ...... tive Committees Working Group.
@nl
P2093
P356
P1476
Preserving renal function in a ...... tive Committees Working Group.
@en
P2093
Elliott WJ
Williams M
P304
P356
10.1053/AJKD.2000.16225
P577
2000-09-01T00:00:00Z